677 results found | searching for "pharma"

First Previous 4 5 6 7 8 9 10 11 12 13 Next Last 
  • Healthcare_medical
  • Protein Expression Market worth $5.4 billion by 2027 https://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html The report "Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027", is expected to reach USD 5.4 billion by 2027 from an estimated USD 2.9 billion in 2022 at a CAGR of 13.3%. Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market. [more]
  • jameshebrew
  • The taste masking market is anticipated to grow at a steady pace till 2035 Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment technologies is expected to rise in the coming years. London Roots Analysis has announced the addition of “Taste masking and Taste Assessment Services and Technologies Market, 2022-2035” report to its list of offerings. The inherent expertise of CMOs and CDMOs in taste masking and taste assessment of bitter drug formulations, along with capabilities to identify globally accepted tastes, develop flavor matching placebo formulations (for testing) having compliance with stringent regulatory guidelines and good clinical practices (GCPs) and proprietary technologies offering significant cost-benefits, have rendered outsourcing as a crucial aspect of taste masked formulation development and production. Key Market Insights Presently, 50 companies claim to offer taste masking and taste assessment services for oral drug formulations Majority (40%, each) of the service providers are based in North America and Europe, followed by companies headquartered in Asia-Pacific (18%). A large proportion (34%) of these companies are large players, followed by small (31%) and mid-sized firms (27%). Close to 30 technology platforms have been developed for taste masking and taste assessment of oral drug formulations Majority (68%) of the technology platforms are used for taste masking and taste assessment of solid oral formulations (tablets, capsules, granules and powder), followed by liquid (10%) oral formulations (suspensions, syrups and solutions). Partnership activity in this field has grown significantly between 2018 and 2021 The maximum number of partnerships were established in 2021 indicating a recent rise in the interest of players engaged in the field of taste masking and taste assessment. It is worth highlighting that majority of the agreements were related to acquisition, representing 46% of the total number of partnerships signed. This is followed by agreements signed for manufacturing of oral drug formulation (13%). More than 460 patents have been filed / granted for taste masking and taste assessment techniques and technologies, since 2017 Close to 60% of the patent applications have been filed by various industry and non-industry players in this domain post 2018. It is worth noting that, around 75% of the patents were filed / granted in the US, followed by European Patent Office (25%). North America is anticipated to capture larger share of the market by 2035 The taste masking market is likely to be driven by technology platforms that employ coating techniques. Further, solid formulations are likely to hold greater market share. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/taste-masking-services-market/request-sample.html The report features inputs from eminent industry stakeholders, who were very optimistic concerning the need of outsourcing of taste masking and taste assessment services in the coming decade. The report includes detailed transcripts of the discussions held with the following industry experts:  Phillipe Tschopp (Head of Business Development, Glatt Pharmaceutical Services)  David Tisi (Director of Technical Operations, Senopsys)  Brandon Keener (Business Development Associate, Adare Pharma Solutions) For additional details, please visit https://www.rootsanalysis.com/reports/taste-masking-services-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • arif12
  • Water Soluble Packaging Market Research Report Growth, Analysis & Forecast, 2020–2027 The Water-Soluble Packaging Market is estimated to grow at a robust CAGR over the forecast period (2020-2027). The factors driving the growth of Water-Soluble Packaging Market includes growing demand for sustainable packaging solutions, increasing use of water-soluble packaging in the end-use industries such as Agriculture, Food and Beverage and Pharmaceutical. For Additional Insights, Click to Access Complete Report - https://www.benedeek.com/blogs/355/Water-Soluble-Packaging-Market-Research-Report-Size-Growth-Analysis-Forecast [more]
  • arif12
  • Water Soluble Packaging Market Research Report Size, Growth, Analysis & Forecast, 2020–2027 The Water-Soluble Packaging Market is estimated to grow at a robust CAGR over the forecast period (2020-2027). The factors driving the growth of Water-Soluble Packaging Market includes growing demand for sustainable packaging solutions, increasing use of water-soluble packaging in the end-use industries such as Agriculture, Food and Beverage and Pharmaceutical. For Additional Insights, Click to Access Complete Report – https://descubre.beqbe.com/water-soluble-packaging-market [more]
  • jameshebrew
  • The DNA and gene cloning services market is anticipated to grow at a CAGR of over 15% In order to avail benefits, such as technical competence, reduced cost, and fast delivery of high-quality DNA and gene customized clones, several players have demonstrated a preference to leverage expertise of DNA and gene cloning service providers. London Roots Analysis has announced the addition of “DNA and Gene Cloning Market , 2022-2035” report to its list of offerings. DNA and gene cloning have diverse applications, including modern biotechnological, medicinal, and several diagnostic ones as DNA and gene cloning has proven to be beneficial for research and development in the biopharmaceutical and healthcare industries. Presently, a number of players having dedicated facilities, cutting-edge machinery, and production lines, are offering DNA and gene cloning services to the various stakeholders in this domain. In 1973, a group of scientists reported that individual genes can be cloned and isolated by cleaving DNA enzymatically into DNA fragments. Over time, gene and DNA cloning has proved to be an important tool for researchers in their studies focused on genetics. To request a sample copy / brochure of this report, please visit link https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market/request-sample.html Key Market Insights Around 80 companies claim to offer DNA and gene cloning services, globally Majority (59%) of the stakeholders are headquartered in North America, followed by those based in Europe (22%), and Asia-Pacific (19%). Further, this segment of the industry is dominated by the presence of small players (11-50 employees), representing 35% of the total service providers. Close to 32% players claim to act as one-stop-shops, offering services for gene synthesis, custom cloning, and sub-cloning Close to 80% of the DNA and gene cloning service providers offer custom cloning, followed by companies offering gene synthesis (68%), sub-cloning (50%), and other services, such as RNA cloning and vector cloning (31%). It is worth mentioning that most of the service providers (61%) offer restriction enzyme-based cloning. Over 1,350 patents related to DNA and gene cloning in biopharmaceutical industry have been filed / granted since 2017 Owing to the increase in research and development efforts by various industry and non-industry players engaged in this domain, close to 60% of patent applications have been filed post-2018. It is worth noting that 57% patents related to DNA and gene cloning have been filed by non-industry players. Close to 6,900 articles related to DNA and gene cloning, have been published in reputed scientific journals since 2018 More than 45% of the articles focused on DNA and gene cloning were published post-2019. Popular journals that have published multiple articles include Methods in Molecular Biology, International Journal of Biological Macromolecules, Developmental and Comparative Immunology, Protein Expression and Purification, and International Journal of Molecular Sciences. Over 35 global events related to DNA and gene cloning have been organized since 2017 Majority of the events related to DNA and gene cloning were organized in Asia-Pacific (64%). It is worth highlighting that the agendas of the events organized post-2020 include discussions on the potential, advancements and challenges associated with DNA and gene cloning techniques. For additional details, please visit https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • globalpharma
  • Largest Pharmaceutical Wholesalers in UK - Global Pharma Distributors As one of the largest wholesale pharmacy suppliers and distributors in the UK, Global Pharma Distributors is the partner of choice for independent pharmacists. https://www.globalpharmadistributoruk.com/
  • globalpharma
  • Wholesale Pharmacy Supplies in UK - Global Pharma Distributors Global Pharma Distributors is a leading UK pharmaceutical wholesaler, distributor, and exporter. We continue to supply high-quality pharmaceuticals to bon-fide registered importers across UK. https://www.globalpharmadistributoruk.com/ordering
  • Jaspercolin
  • The healthcare industry has grown into a highly competitive environment, Because of the competitive pricing, numerous options, and patients’ growing expectations for optimal care. JCR Healthcare Panel’s diverse set of respondents comprises physicians, allied healthcare professionals, surgeons, and patients across the globe to ensure high-quality insights. We provide real-world healthcare intelligence to industry leaders and niche professionals to stay ahead of the competition. Contact us to know more about the panel: https://cutt.ly/vENMH2I #Jaspercolin #marketresearch #pharmaceuticals #healthcare
  • jameshebrew
  • The human microbiome market is anticipated to grow at a CAGR of 24% till 2035 With the increasing concept of precision medicine, several scientists have demonstrated interest in the therapeutic manipulation of human microbiome (commonly gut bacteria) for the treatment of a wide range of disease indications. Roots Analysis has announced the addition of “The Human Microbiome Market, (4th Edition) 2022-2035” report to its list of offerings. The microbiome-based therapies pipeline features six drugs in phase III clinical development, over 200 candidates in other clinical and preclinical stages of development along with more than 60 diagnostics and screening / profiling tests that are commercialized for the detection of various diseases. However, the current microbiome market is driven by the fecal microbiota therapies approved by the FDA, particularly for the recurrent CDI and the commercialized diagnostic tests available to the patients. The human microbiome remained a largely unexplored area until 2007 when the Human Microbiome Project (HMP) was initiated. Given the role of microbiota in disease development and pathogenesis, the concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, thereby, defining a new frontier in the field of medicine. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/281/request-sample.html Key Market Insights Over 230 drug candidates are currently being developed by more than 70 drug developers Nearly 30% of the pipeline drugs are in clinical phase of development, while more than 150 drugs are in preclinical and discovery stages. Clinical stage drugs are primarily being developed for infectious diseases and digestive disorders, while candidates in preclinical and discovery stages are focused on oncological disorders. More than 75 diagnostics and screening / profiling test are available / under development Of these, around 80% of the tests are available in the market, while rest are under development. More than 40 companies are engaged in providing these tests; these are primarily based in North America (45%) and Europe (39%). It is worth highlighting that majority (68%) of the players are small companies. FMTs are the only commercially available microbiome therapies approved by the FDA These therapies are primarily used for the treatment of recurrent Clostridium difficile infection (rCDIs). It is worth mentioning that more than 400 trials have been registered for evaluating these therapies for a wide range of indications. Partnership activity in this domain has increased at a CAGR of 26%, between 2017 and 2021 Maximum number of partnerships were established in 2021, indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that majority of the deals were R&D agreements, representing over 35% of the total number of partnerships signed in the given time period. More than USD 1 billion has been invested by both private and public investors, since 2017 Of the total amount invested, over USD 563 million was raised through venture capital financing, representing over 56% of the overall funding activity in this domain. Further, 36 instances of grants / awards were also reported, wherein players collectively raised more than USD 137 million. Outsourcing has become an integral part of the microbiome and live biotherapeutics development process Presently, over 25 service providers claim to offer a multitude of contract manufacturing services for microbiome and live biotherapeutic products. It is worth noting that close to 10 firms were established post 2010 and around 45% of the players are located in Europe. Microbiome therapeutics are anticipated to capture more than 60% share of total microbiome market by 2035 As late-stage therapeutics will get approved by the FDA in the foreseen future, the microbiome therapeutics market is likely to grow at an annualized rate of 37% till 2035. It is worth mentioning that microbiome diagnostics is likely to capture 20% of the total microbiome market share by 2035. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • 5starelk
  • What is more, due to such a lot of confusion revolving around High-Risk Merchant Account Online Pharmacy or low-risk accounts, it may very well be trying to find a high-risk merchant administration. https://writeupcafe.com/all-about-high-risk-merchant-account-online-pharmacy/ [more]
First Previous 4 5 6 7 8 9 10 11 12 13 Next Last